Navigation Links
Discover The Mutter Museum After Dark
Date:9/5/2007

One of Philadelphia's Most Popular Museums Will Keep Its Doors Open Late

Friday Nights This Fall

PHILADELPHIA, Sept. 5 /PRNewswire/ -- Looking for an unusual, eye-opening way to spend a Friday evening? Try the Mutter Museum, home to one of the most intriguing medical collections on public display in the world, including wax models, fluid-preserved anatomical and pathological specimens, and skeletal and dried specimens. The Mutter Museum will extend its normal operating hours and remain open until 9 p.m. on Friday nights beginning Sept. 14.

"In response to the Mutter's increasing popularity we are expanding our hours on Fridays," said Andrea Kenyon, Museum Director. "By staying open late, we are offering visitors a unique way to start their weekend."

To further add to the enjoyment of a Friday night visit, the Mutter is hosting a series of events, starting with a Sept. 21 mixer for students from colleges and universities in the region. On Oct. 26, the Mutter screens the 1985 cult film "The Doctor and the Devils," and on Nov. 2, Dana Kollmann, author of "Never Suck a Dead Man's Hand: Curious Tales of a CSI," will enthrall visitors with stories from the morgue and of her life as an actual Crime Scene Investigator.

Friday evening visitors also will have access to the Mutter's new Cell Phone Audio Guide; a free, interactive tour that offers more in-depth information about some of the museum's popular and unique pieces. Visitors will learn about such one-of-a-kind treasures as the preserved body of "The Soap Lady" and the tallest skeleton on display in North America.

The Mutter Museum at The College of Physicians of Philadelphia was originally founded to educate future doctors about anatomy and human medical anomalies. Today, it serves as a valuable resource for educating and enlightening the public about our medical past and telling important stories about what it means to be human. The Mutter Museum embodie
'/>"/>

SOURCE Mutter Museum
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. PRIMARY PULMONARY HYPERTENSION GENE DISCOVERED
2. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
3. Poisonous Parkinsons molecule discovered
4. Discovery of bone gene
5. Genes for Vision discovered
6. Chemists Discover Cation Considered Too Unstable To Exist
7. New breast cancer genes discovered
8. Latest discovery on Autism
9. Bacterial discovery may help CF patients
10. A new discovery about Acetaminophen
11. A new discovery about Acetaminophen
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Within3 Expands into Mobile Applications 2Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 2Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 3Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 4Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 5Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 6Onyx Pharmaceuticals to Webcast Analyst Briefing on Development Program 2Cardiac Science Appoints Healthcare Executive Ronald A Andrews Jr to Board of Directors 6032 1Cardiac Science Appoints Healthcare Executive Ronald A Andrews Jr to Board of Directors 6032 2Cardiac Science Appoints Healthcare Executive Ronald A Andrews Jr to Board of Directors 6032 3Cardiac Science Appoints Healthcare Executive Ronald A Andrews Jr to Board of Directors 6032 4Cardiac Science Appoints Healthcare Executive Ronald A Andrews Jr to Board of Directors 6032 5InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 6027 1InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 6027 2InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 6027 3InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 6027 4InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 6027 5InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 6027 6InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 6027 7InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 6027 8InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 6027 9InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 6027 10InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 6027 11InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 6027 12InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 6027 13Jazz Pharmaceuticals Announces Third Quarter 2009 Financial Results 6022 1Jazz Pharmaceuticals Announces Third Quarter 2009 Financial Results 6022 2Jazz Pharmaceuticals Announces Third Quarter 2009 Financial Results 6022 3Jazz Pharmaceuticals Announces Third Quarter 2009 Financial Results 6022 4Jazz Pharmaceuticals Announces Third Quarter 2009 Financial Results 6022 5Jazz Pharmaceuticals Announces Third Quarter 2009 Financial Results 6022 6Jazz Pharmaceuticals Announces Third Quarter 2009 Financial Results 6022 7